melanotic peripheral nerve sheath tumor A) Malignant (MMNST) composed by Frontiers | Case Report: Anlotinib
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Frontiers Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor Pathology Outlines Malignant peripheral nerve sheath tumor (MPNST) Malignant Peripheral Nerve Sheath Tumor Presenting as Horners Syndrome Cureus View of Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C and GNAQ mutations Free Neuropathology
Store: larengifo.com · Domain: larengifo.com




























